Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Sociodemographic and clinical characteristics of participants stratified by intervention and control groups (presented as n (%) or mean ± standard deviation)

From: The cost effectiveness of a multidomain intervention on physical, cognitive, vascular, dietary and psychosocial outcomes among community dwelling older adults with cognitive frailty in Malaysia: The AGELESS Trial

Parameter

Intervention Group (n = 53)

Control Group(n = 53)

Total (n = 106)

p-value

Age

67.71 5.6

68.42 5.2

68.1 ± 5.5

0.52

Age Group

   

0.56

60–69 years

35 (66.0%)

32 (60.4%)

67(63.2%)

 

70–79 years

17 (32.1%)

18 (34.0%)

35 (33.0%)

 

80 + years

1 (1.9%)

3 (5.6%)

4 (3.8%)

 

Gender

   

1

Male

22 (41.5%)

22 (41.5%)

44 (41.5%)

 

Female

31 (58.5%)

31 (58.5%)

62 (58.5%)

 

Ethnicity

   

0.69

Malay

47 (88.7%)

41 (77.4%)

88 (83%)

 

Chinese

1 (1.9%)

3 (5.7%)

4 (3.8%)

 

Indian

5 (9.4%)

9 (16.9%)

14 (13.2%)

 

Marital Status

   

0.85

Unmarried/widow/divorced

27 (50.9%)

29 (54.7%)

56 (52.8%)

 

Married

26 (49.1%)

24 (45.3%)

50 (47.2%)

 

Living Arrangement

    

Lives Alone

8 (15.1%)

7 (13.2%)

15 (14.2%)

0.87

With others

45 (84.9%)

46 (86.8%)

91 (85.8%)

 

Education years

8.8 ± 2.9

7.8 ± 4.7

8.3 ± 3.9

0.20

Occupation status

   

0.87

Not working

47 (88.7%)

46 (86.8%)

93 (87.7%)

 

Working

6 (11.3%)

7 (13.2%)

13 (12.3%)

 

Monthly income (MYR)

1306.1 ± 1420.5

1106.6 ± 987.5

1205.4 ± 1219.5

0.41

Polypharmacy

    

Yes

1 (1.9%)

4 (7.5%)

5 (4.7%)

 

No

52 (98.1%)

49 (92.5%)

101 (95.3%)

 

Multimorbidity

   

0.89

Yes

31 (58.5%)

32 (60.4%)

63 (59.4%)

 

No

22 (41.5%)

21 (39.6%)

43 (40.6%)

 

Smoking status

    

Smoker

12 (22.6)

4 (7.5)

16 (15.1)

0.06

Non smoker/past smoker

41 (77.4)

49 (92.5)

90 (84.9)

 

Family history of dementia

    

Yes

4 (7.5%)

5 (9.4%)

9 (8.5%)

0.54

No

49 (92.5%)

48 (90.6%)

97 (91.5%)

 

Hypertension

    

Yes

36 (67.9%)

34 (64.2%)

70 (66%)

0.84

No

17 (32.1%)

19 (35.8%)

36 (34%)

 

Hypercholesterolemia

    

Yes

30 (56.6%)

30 (56.6%)

60 (56.6%)

1.00

No

23 (43.4%)

23 (43.4%)

46 (43.4%)

 

Diabetes

    

Yes

30 (56.6%)

30 (56.6%)

60 (56.6%)

1.00

No

23 (43.4%)

23 (43.4%)

46 (43.4%)

 

Cognitive Frailty

   

0.40

Pre-CF

47 (88.7%)

44 (83%)

91 (85.9%)

 

CF

6 (11.3%)

9 (17%)

15 (14.1%)